PURE BiosciencePURE BiosciencePURE Bioscience

PURE Bioscience

No trades
See on Supercharts
Next report date
Report period
Q3 2024
EPS estimate
Revenue estimate
Market capitalization
‪7.83 M‬USD
−0.0326USD
‪−3.96 M‬USD
‪1.88 M‬USD
‪31.46 M‬
Beta (1Y)
−1.00

About PURE Bioscience

CEO
Robert F. Bartlett
Headquarters
Rancho Cucamonga
Employees (FY)
12
Founded
1992
FIGI
BBG000BVNM59
PURE Bioscience, Inc. engages in the discovery, development, and commercialization of proprietary antimicrobial products for pathogen and hygienic control. It offers silver dihydrogen citrate-based disinfecting and sanitizing products. The company was founded by Michael L. Krall on August 24, 1992 and is headquartered in Rancho Cucamonga, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of PURE is 0.0700 USD — it has decreased by 12.50% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange PURE Bioscience stocks are traded under the ticker PURE.
PURE Bioscience is going to release the next earnings report on Jun 12, 2024. Keep track of upcoming events with our Earnings Calendar.
PURE stock is 19.40% volatile and has beta coefficient of −1.00. Check out the list of the most volatile stocks — is PURE Bioscience there?
Yes, you can track PURE Bioscience financials in yearly and quarterly reports right on TradingView.
PURE stock has risen by 4.48% compared to the previous week, the month change is a 29.29% fall, over the last year PURE Bioscience has showed a 36.36% decrease.
PURE net income for the last quarter is ‪−1.00 M‬ USD, while the quarter before that showed ‪−735.00 K‬ USD of net income which accounts for −36.33% change. Track more PURE Bioscience financial stats to get the full picture.
Today PURE Bioscience has the market capitalization of ‪7.83 M‬, it has increased by 19.40% over the last week.
No, PURE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PURE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PURE Bioscience stock right from TradingView charts — choose your broker and connect to your account.
PURE reached its all-time high on Nov 14, 2007 with the price of 69.7600 USD, and its all-time low was 0.0630 USD and was reached on Apr 16, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 25, 2024, the company has 12.00 employees. See our rating of the largest employees — is PURE Bioscience on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PURE Bioscience technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PURE Bioscience stock shows the sell signal. See more of PURE Bioscience technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PURE Bioscience EBITDA is ‪−3.14 M‬ USD, and current EBITDA margin is −187.05%. See more stats in PURE Bioscience financial statements.